TerminatedNot applicableNCT00253552

G-CSF-Treated Donor Bone Marrow Transplant in Treating Patients With Hematologic Disorders

Studying Acute mast cell leukemia

Last synced from ClinicalTrials.gov May 7, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: OHSU Knight Cancer Institute
Principal Investigator: Eneida Nemecek, MD
OHSU Knight Cancer Institute
Intervention: filgrastim(biological)
Enrollment: 4 enrolled
Eligibility: 24 years · All sexes
Timeline: 2004 – 2006

Study locations (1)

OHSU Knight Cancer Institute, Portland, Oregon, United States

Collaborators

National Cancer Institute (NCI)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT00253552 on ClinicalTrials.gov

Other trials for Acute mast cell leukemia

Additional recruiting or active studies for the same condition.

RECRUITINGPHASE1, PHASE2NCT06213636
Fourth-gen CAR T Cells Targeting CD19/CD22 for Highly Resistant B-cell Lymphoma/Leukemia (PMBCL/CNS-BCL).
Essen Biotech

See all trials for Acute mast cell leukemia →

← Back to all trials